Parameters and Morphological Changes of Erythrocytes and Platelets of COVID-19 Subjects: A Longitudinal Cohort Study

References

• Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R. The role of Th17 response in COVID-19. Cells Basel. 2021;10(6). doi:10.3390/cells10061550
   Google Scholar
• Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg. 2021;104(4):1188–1201. doi:10.4269/ajtmh.20-1536
   PubMed Web of Science ®Google Scholar
• Slomka A, Martucci G, Raffa GM, et al. Immunological and hematological response in COVID-19. Adv Exp Med Biol. 2021;1352:73–86. doi:10.1007/978-3-030-85109-5_5
   PubMedGoogle Scholar
• Slomka A, Kowalewski M, Zekanowska E. Coronavirus disease 2019 (COVID-19): a short review on hematological manifestations. Pathogens. 2020;9(6). doi:10.3390/pathogens9060493
   PubMed Web of Science ®Google Scholar
• Sarkar S, Kannan S, Khanna P, Singh AK. Role of red blood cell distribution width, as a prognostic indicator in COVID-19: a systematic review and meta-analysis. Rev Med Virol. 2022;32(2):e2264. doi:10.1002/rmv.2264
   PubMed Web of Science ®Google Scholar
• Lippi G, Henry BM, Sanchis-Gomar F. Red blood cell distribution is a significant predictor of severe illness in coronavirus disease 2019. Acta Haematol Basel. 2021;144(4):360–364. doi:10.1159/000510914
   PubMed Web of Science ®Google Scholar
• Ycas JW, Horrow JC, Horne BD. Persistent increase in red cell size distribution width after acute diseases: a biomarker of hypoxemia? Clin Chim Acta. 2015;448:107–117. doi:10.1016/j.cca.2015.05.021
   PubMed Web of Science ®Google Scholar
• Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care. 2011;15(4):R194. doi:10.1186/cc10355
   PubMed Web of Science ®Google Scholar
• Hsieh YP, Chang CC, Kor CT, Yang Y, Wen YK, Chiu PF. Mean corpuscular volume and mortality in patients with CKD. Clin J Am Soc Nephro. 2017;12(2):237–244. doi:10.2215/CJN.00970116
   PubMed Web of Science ®Google Scholar
• Bateman RM, Sharpe MD, Singer M, Ellis CG. The effect of sepsis on the erythrocyte. Int J Mol Sci. 2017;18(9):1932. doi:10.3390/ijms18091932
   PubMed Web of Science ®Google Scholar
• Bergamaschi G, Borrelli DAF, Aronico N, et al. Anemia in patients with COVID-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):239–246. doi:10.1007/s10238-020-00679-4
   PubMed Web of Science ®Google Scholar
• Hornick A, Tashtish N, Osnard M, et al. Anisocytosis is associated with short-term mortality in COVID-19 and may reflect proinflammatory signature in uninfected ambulatory adults. Pathog Immun. 2020;5(1):312–326. doi:10.20411/pai.v5i1.391
   PubMedGoogle Scholar
• Grau M, Ibershoff L, Zacher J, et al. Even patients with mild COVID-19 symptoms after SARS-CoV-2 infection show prolonged altered red blood cell morphology and rheological parameters. J Cell Mol Med. 2022;26(10):3022–3030. doi:10.1111/jcmm.17320
   PubMed Web of Science ®Google Scholar
• de Almeida DC, Franco M, Dos DRP, et al. Acute kidney injury: incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One. 2021;16(5):e0251048. doi:10.1371/journal.pone.0251048
   PubMed Web of Science ®Google Scholar
• Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327–358. doi:10.1152/physrev.00016.2011
   PubMed Web of Science ®Google Scholar
• Middleton EA, Weyrich AS, Zimmerman GA. Platelets in pulmonary immune responses and inflammatory lung diseases. Physiol Rev. 2016;96(4):1211–1259. doi:10.1152/physrev.00038.2015
   PubMed Web of Science ®Google Scholar
• Morrell CN, Aggrey AA, Chapman LM, Modjeski KL. Emerging roles for platelets as immune and inflammatory cells. Blood. 2014;123(18):2759–2767. doi:10.1182/blood-2013-11-462432
   PubMed Web of Science ®Google Scholar
• Atik D, Kaya HB. Evaluation of the relationship of mpv, rdw and pvi parameters with disease severity in COVID-19 patients. Acta Clin Croat. 2021;60(1):103–114. doi:10.20471/acc.2021.60.01.15
   PubMed Web of Science ®Google Scholar
• Ozder A. A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetes. Diabetes Res Clin Pr. 2020;166:108294. doi:10.1016/j.diabres.2020.108294
   PubMed Web of Science ®Google Scholar
• Akar T. Can mean platelet volume indicate helicobacter positivity and severity of gastric inflammatIon? An orIgInal study and revIew of the lIterature. Acta Clin Croat. 2019;58(4):576–582. doi:10.20471/acc.2019.58.04.02
   PubMed Web of Science ®Google Scholar
• Zaccardi F, Rocca B, Pitocco D, Tanese L, Rizzi A, Ghirlanda G. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis. Diabetes Metab Res. 2015;31(4):402–410. doi:10.1002/dmrr.2625
   Web of Science ®Google Scholar
• Khan HA, Alhomida AS, Sobki SH, Moghairi AA, Koronki HE. Blood cell counts and their correlation with creatine kinase and C-reactive protein in patients with acute myocardial infarction. Int J Clin Exp Med. 2012;5(1):50–55.
   PubMed Web of Science ®Google Scholar
• Lichtenberger LM, Szabo S. A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection. Inflammopharmacology. 2022;30(4):1475–1476. doi:10.1007/s10787-022-01015-w
   PubMed Web of Science ®Google Scholar
• Rampotas A, Pavord S. Platelet aggregates, a marker of severe COVID-19 disease. J Clin Pathol. 2021;74(11):750–751. doi:10.1136/jclinpath-2020-206933
   PubMed Web of Science ®Google Scholar
• Ahnach M, Ousti F, Nejjari S, Houssaini MS, Dini N. Peripheral blood smear findings in COVID-19. Turk J Hematol. 2020;37(4):310. doi:10.4274/tjh.galenos.2020.2020.0262
   PubMed Web of Science ®Google Scholar
• Pezeshki A, Vaezi A, Nematollahi P. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J Hematop. 2021;14(3):221–228. doi:10.1007/s12308-021-00459-3
   PubMed Web of Science ®Google Scholar
• Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L, Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus Italy. 2021;19(1):34–36. doi:10.2450/2020.0242-20
   PubMed Web of Science ®Google Scholar
• Gerard D, Ben BS, Lesesve JF, Perrin J. Are mushroom-shaped erythrocytes an indicator of COVID-19? Brit J Haematol. 2021;192(2):230. doi:10.1111/bjh.17127
   PubMed Web of Science ®Google Scholar
• Khakwani M, Horgan C, Ewing J. COVID-19-associated oxidative damage to red blood cells. Brit J Haematol. 2021;193(3):481. doi:10.1111/bjh.17317
   PubMed Web of Science ®Google Scholar
• NHCPRC (National Health Commission of the PRC). Diagnosis and treatment protocol for COVID-19 (trial version 5); 2020. Available from: http://www.nhc.gov.cn/jkj/s3577/202002/a5d6f7b8c48c451c87dba14889b30147.shtml. Accessed March 3, 2023.
   Google Scholar
• Chi H, Zhou K, Shen L, et al. The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: a longitudinal cohort study. Int Immunopharmacol. 2022;110:109019. doi:10.1016/j.intimp.2022.109019
   PubMed Web of Science ®Google Scholar
• Barbara HO. A Color Atlas and Instruction Manual of Peripheral Blood Cell Morphology. Lippincott Williams & Wikins; 1984.
   Google Scholar
• Thon JN, Italiano JE. Platelets: production, morphology and ultrastructure. Handb Exp Pharmacol. 2012;2012(210):3–22. doi:10.1007/978-3-642-29423-5_1
   Google Scholar
• Lu G, Wang J. Dynamic changes in routine blood parameters of a severe COVID-19 case. Clin Chim Acta. 2020;508:98–102. doi:10.1016/j.cca.2020.04.034
   PubMed Web of Science ®Google Scholar
• Petelina TI, Musikhina NA, Avdeeva KS, et al. Estimation of erythrocyte parameters of general blood analysis in patients with SARS-CoV-2 -associated pneumonia. Klin Lab Diagn. 2022;67(1):24–30. doi:10.51620/0869-2084-2022-67-1-24-30
   PubMedGoogle Scholar
• Rostoff P, Siniarski A, Haberka M, Konduracka E, Nessler J, Gajos G. Relationship among the leptin-to-adiponectin ratio, systemic inflammation, and anisocytosis in well-controlled type 2 diabetic patients with atherosclerotic cardiovascular disease. Kardiol Pol. 2020;78(5):420–428. doi:10.33963/KP.15257
   PubMed Web of Science ®Google Scholar
• Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Cl Lab Sci. 2015;52(2):86–105. doi:10.3109/10408363.2014.992064
   PubMed Web of Science ®Google Scholar
• Fancellu A, Zinellu A, Mangoni AA, et al. Red blood cell distribution width (RDW) correlates to the anatomical location of colorectal cancer. implications for clinical use. J Gastrointest Canc. 2022;53(2):259–264. doi:10.1007/s12029-021-00582-5
   PubMed Web of Science ®Google Scholar
• Rajab AM, Rahman S, Rajab TM, Haider KH. Morphology and chromic status of red blood cells are significantly influenced by gestational diabetes. J Hematol. 2018;7(4):140–148. doi:10.14740/jh449w
   PubMedGoogle Scholar
• Damjanovska S, Davitkov P, Gopal S, et al. High red cell distribution width and low absolute lymphocyte count associate with subsequent mortality in HCV infection. Pathog Immun. 2021;6(2):90–104. doi:10.20411/pai.v6i2.467
   PubMedGoogle Scholar
• Kogika MM, Lustoza MD, Hagiwara MK, Caragelasco DS, Martorelli CR, Mori CS. Evaluation of oxidative stress in the anemia of dogs with chronic kidney disease. Vet Clin Path. 2015;44(1):70–78. doi:10.1111/vcp.12225
   PubMed Web of Science ®Google Scholar
• Xi H, Li C, Ren F, Zhang H, Zhang L. Telomere, aging and age-related diseases. Aging Clin Exp Res. 2013;25(2):139–146. doi:10.1007/s40520-013-0021-1
   PubMed Web of Science ®Google Scholar
• Aviv A. Telomeres and COVID-19. FASEB J. 2020;34(6):7247–7252. doi:10.1096/fj.202001025
   PubMed Web of Science ®Google Scholar
• Chernyak BV, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and oxidative stress. Biochem Mosc. 2020;85(12):1543–1553. doi:10.1134/S0006297920120068
   PubMed Web of Science ®Google Scholar
• Kiefer CR, Snyder LM. Oxidation and erythrocyte senescence. Curr Opin Hematol. 2000;7(2):113–116. doi:10.1097/00062752-200003000-00007
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interf Cytok Res. 1998;18(8):555–559. doi:10.1089/jir.1998.18.555
   PubMed Web of Science ®Google Scholar
• Taneri PE, Gomez-Ochoa SA, Llanaj E, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763–773. doi:10.1007/s10654-020-00678-5
   PubMed Web of Science ®Google Scholar
• Begemann M, Gross O, Wincewicz D, et al. Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. Mol Med. 2021;27(1):120. doi:10.1186/s10020-021-00381-5
   PubMed Web of Science ®Google Scholar
• Han X, Ye Q. Kidney involvement in COVID-19 and its treatments. J Med Virol. 2021;93(3):1387–1395. doi:10.1002/jmv.26653
   PubMed Web of Science ®Google Scholar
• Kario K, Matsuo T, Nakao K, Yamaguchi N. The correlation between red cell distribution width and serum erythropoietin titres. Clin Lab Haematol. 1991;13(2):222–223. doi:10.1111/j.1365-2257.1991.tb00274.x
   PubMedGoogle Scholar
• Tekce H, Kin TB, Aktas G, Tanrisev M, Sit M. The evaluation of red cell distribution width in chronic hemodialysis patients. Int J Nephrol. 2014;2014:754370. doi:10.1155/2014/754370
   PubMedGoogle Scholar
• Afonso L, Zalawadiya SK, Veeranna V, Panaich SS, Niraj A, Jacob S. Relationship between red cell distribution width and microalbuminuria: a population-based study of multiethnic representative US adults. Nephron. 2011;119(4):c277–82. doi:10.1159/000328918
   PubMed Web of Science ®Google Scholar
• Zaid Y, Puhm F, Allaeys I, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127(11):1404–1418. doi:10.1161/CIRCRESAHA.120.317703
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu Y, Wang X, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. doi:10.1186/s13045-020-00954-7
   PubMed Web of Science ®Google Scholar
• Gao Y, Li Y, Yu X, et al. The impact of various platelet indices as prognostic markers of septic shock. PLoS One. 2014;9(8):e103761. doi:10.1371/journal.pone.0103761
   PubMed Web of Science ®Google Scholar
• Koupenova M, Corkrey HA, Vitseva O, et al. SARS-CoV-2 initiates programmed cell death in platelets. Circ Res. 2021;129(6):631–646. doi:10.1161/CIRCRESAHA.121.319117
   PubMed Web of Science ®Google Scholar
• Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso study, Tromso, Norway. J Thromb Haemost. 2010;8(1):157–162. doi:10.1111/j.1538-7836.2009.03498.x
   PubMed Web of Science ®Google Scholar
• Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010;8(1):148–156. doi:10.1111/j.1538-7836.2009.03584.x
   PubMed Web of Science ®Google Scholar
• Taha M, Sano D, Hanoudi S, et al. Platelets and renal failure in the SARS-CoV-2 syndrome. Platelets. 2021;32(1):130–137. doi:10.1080/09537104.2020.1817361
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM. Coronavirus disease 2019-associated coagulopathy. Mayo Clin Proc. 2021;96(1):203–217. doi:10.1016/j.mayocp.2020.10.031
   PubMed Web of Science ®Google Scholar
• Puhm F, Allaeys I, Lacasse E, et al. Platelet activation by SARS-CoV-2 implicates the release of active tissue factor by infected cells. Blood Adv. 2022;6(12):3593–3605. doi:10.1182/bloodadvances.2022007444
   PubMed Web of Science ®Google Scholar
• Shen S, Zhang J, Fang Y, et al. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism. J Hematol Oncol. 2021;14(1):72. doi:10.1186/s13045-021-01082-6
   PubMed Web of Science ®Google Scholar
• Benati M, Salvagno GL, Nitto S, et al. thrombin generation in patients with coronavirus disease 2019. Semin Thromb Hemost. 2021;47(4):447–450. doi:10.1055/s-0041-1722844
   PubMedGoogle Scholar
• Malas MB, Naazie IN, Elsayed N, Mathlouthi A, Marmor R, Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. Eclinicalmedicine. 2020;29:100639. doi:10.1016/j.eclinm.2020.100639
   PubMedGoogle Scholar
• Makowski M, Smorag I, Makowska J, et al. Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation. Int J Cardiol. 2017;235:1–5. doi:10.1016/j.ijcard.2017.03.023
   PubMed Web of Science ®Google Scholar
• Michalak A, Cichoz-Lach H, Guz M, Kozicka J, Cybulski M, Jeleniewicz W. Plateletcrit and mean platelet volume in the evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients. Biomed Res Int. 2021;2021:8867985. doi:10.1155/2021/8867985
   PubMed Web of Science ®Google Scholar
• Guo F, Zhu X, Qin X. Platelet distribution width in hepatocellular carcinoma. Med Sci Monitor. 2018;24:2518–2523.
   PubMed Web of Science ®Google Scholar
• Guclu E, Kocayigit H, Okan HD, et al. Effect of COVID-19 on platelet count and its indices. Rev Assoc Med Bras. 2020;66(8):1122–1127. doi:10.1590/1806-9282.66.8.1122
   PubMed Web of Science ®Google Scholar
• Ozcelik N, Ozyurt S, Yilmaz KB, Gumus A, Sahin U. The value of the platelet count and platelet indices in differentiation of COVID-19 and influenza pneumonia. J Med Virol. 2021;93(4):2221–2226. doi:10.1002/jmv.26645
   PubMed Web of Science ®Google Scholar